Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Non-Hodgkin’s Lymphoma: Pathogenesis, Clinical Presentation, and Treatment

  • Chapter
HIV & HTLV-I Associated Malignancies

Part of the book series: Cancer Treatment and Research ((CTAR,volume 104))

Abstract

Non-Hodgkin’s lymphomas (NHL) became associated with HIV infection early in the course of the AIDS epidemic. Although NHL was first noted to be increased in young gay men1-8it soon became clear that it afflicted all subsets of HIV infected patients9-11 While AIDS-related lymphoma remains one of the most lethal complications of HIV disease12the management and outcomes of patients with this disease have changed over the last several years. This chapter will discuss current concepts surrounding AIDS-related lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levine AM, Meyer PR, Begandy MK, et al: Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings. Aim Intern Med 100:7–13, 1984

    CAS  Google Scholar 

  2. Kalter SP, Riggs SA, Cabanillas F, et al: Aggressive non-Hodgkin’s lymphomas in immunocompromised homosexual males. Blood 66:655–9, 1985

    PubMed  CAS  Google Scholar 

  3. Harnly ME, Swan SH, Holly EA, et al: Temporal trends in the incidence of non-Hodgkin’s lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS) [see comments]. Am J Epidemiol 128:261–7, 1988

    PubMed  CAS  Google Scholar 

  4. Ioachim HL, Dorsett B, Cronin W, et al: Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 22:659–73, 1991

    Article  PubMed  CAS  Google Scholar 

  5. Ross R, Dworsky R, Paganini-Hill A, et al: Non-Hodgkin’s lymphomas in never married men in Los Angeles. Br J Cancer 52:785–7, 1985

    Article  PubMed  CAS  Google Scholar 

  6. Ziegler JL, Beckstead JA, Volberding PA, et al: Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–70, 1984

    Article  PubMed  CAS  Google Scholar 

  7. Levine AM, Gill PS, Meyer PR, et al: Retrovirus and malignant lymphoma in homosexual men. Jama 254:1921–5, 1985

    Article  PubMed  CAS  Google Scholar 

  8. Levine AM, Burkes RL, Walker M, et al: B-cell lymphoma in two monogamous homosexual men. Arch Intern Med 145:479–81, 1985

    Article  PubMed  CAS  Google Scholar 

  9. Beral V, Peterman T, Berkelman R, et al: AIDS-associated non-Hodgkin lymphoma [see comments]. Lancet 337:805–9, 1991

    Article  PubMed  CAS  Google Scholar 

  10. Goedert JJ, Cote TR, Virgo P, et al: Spectrum of AIDS-associated malignant disorders [see comments]. Lancet 351:1833–9, 1998

    Article  PubMed  CAS  Google Scholar 

  11. Rabkin CS, Hilgartner MW, Hedberg KW, et al: Incidence of lymphomas and other cancers in HIV-infected and HIV- uninfected patients with hemophilia. Jama 267:1090–4, 1992

    Article  PubMed  CAS  Google Scholar 

  12. Chaisson RE, Gallant JE, Keruly JC, et al: Impact of opportunistic disease on survival in patients with HIV infection. AIDS 12:29–33, 1998

    Article  PubMed  CAS  Google Scholar 

  13. National Cancer Institute sponsored study of classifications of non- Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. Cancer 49:2112–35, 1982

    Article  Google Scholar 

  14. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome for national reporting--United States. MMWR 36:1, 1987

    Google Scholar 

  15. IARC working group on the evaluation of carcinogenic risks to humans.human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon, France, 1–18 June 1996. IARC monographs on the evaluation of carcinogenic risks to humans 67:1–424, 1996

    Google Scholar 

  16. Beral V, Bull D, Darby S, et al: Risk of Kaposi’s sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS [see comments] Lancet 339:632–5, 1992

    Article  PubMed  CAS  Google Scholar 

  17. Moore RD, Kessler H, Richman DD, et al: Non-Hodgkin’s lymphoma in patients with advanced HIV infection treated with zidovudine. Jama 265:2208–11, 1991

    Article  PubMed  CAS  Google Scholar 

  18. Pluda JM, Yarchoan R, Jaffe ES, et al: Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 113:276–82, 1990

    PubMed  CAS  Google Scholar 

  19. Pluda JM, Venzon DJ, Tosato G, et al: Parameters affecting the development of non-Hodgkin’s lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11:1099–107, 1993

    PubMed  CAS  Google Scholar 

  20. Spina M, Vaccher E, Carbone A, et al: Neoplastic complications of HIV infection. Ann Oncol 10:1271–1286, 1999

    Article  PubMed  CAS  Google Scholar 

  21. Levine AM: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8, 1992

    PubMed  CAS  Google Scholar 

  22. Carbone A, Gloghini A, Gaidano G, et al: AIDS-related Burkitt’s lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 103:561–7, 1995

    PubMed  CAS  Google Scholar 

  23. Levine AM, Sullivan-Halley J, Pike MC, et al: Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival [see comments]. Cancer 68:2466–72, 1991

    Article  PubMed  CAS  Google Scholar 

  24. Egger M, Hirschel B, Francioli P, et al: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 315:1194–1199, 1997

    Article  PubMed  CAS  Google Scholar 

  25. Hogg R, O’Shaughnessy M, Gataric N, et al: Decline in deaths from AIDS due to new antiretrovirals (letter). Lancet 349:1294, 1997

    Article  PubMed  CAS  Google Scholar 

  26. Detels R, Munoz A, McFarlane G, et al: Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 280:1497–1503, 1998

    Article  PubMed  CAS  Google Scholar 

  27. Palella FJ, Jr., Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators [see comments]. N Engl J Med 338:853–60, 1998

    Article  PubMed  Google Scholar 

  28. Sparano JA, Anand K, Desai J, et al: Effect of highly active antiretroviral therapy on the incidence of HIV- associated malignancies at an urban medical center. J Acquir Immune Defic Syndr 21 Suppl 1:S18–22, 1999

    PubMed  CAS  Google Scholar 

  29. Jacobson LP, Yamashita TE, Detels R, et al: Impact of potent antiretroviral therapy on the incidence of Kaposi’s sarcoma and non-Hodgkin’s lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 21 Suppl 1:S34–41, 1999

    Google Scholar 

  30. Rabkin CS, Testa MA, Huang J, et al: Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Synch 21 Suppl 1:S31–3, 1999

    CAS  Google Scholar 

  31. Buchbinder SP, Holmberg SD, Scheer S, et al: Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 21 Suppl 1:523–6, 1999

    Google Scholar 

  32. Grulich AE: AIDS-associated non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 21 Suppl 1:S27–30, 1999

    PubMed  CAS  Google Scholar 

  33. Waldmann TA, Misiti J, Nelson DL, et al: Ataxia-telangiectasia: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia [clinical conference]. Ann Intern Med 99:367–79, 1983

    PubMed  CAS  Google Scholar 

  34. Cotelingam JD, Witebsky FG, Hsu SM, et al: Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest 3:515–22, 1985

    Article  PubMed  CAS  Google Scholar 

  35. Purtilo DT: Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Adv Cancer Res 34:279–312, 1981

    Article  PubMed  CAS  Google Scholar 

  36. Frizzera G, Rosai J, Dehner LP, et al: Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer 46:692–9, 1980

    Article  PubMed  CAS  Google Scholar 

  37. Grierson H, Purtilo DT: Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 106:538–45, 1987

    PubMed  CAS  Google Scholar 

  38. Lenoir GM DH-H: Lymphoma and immunocompromised hosts. In: Revillard JP, Wierzbicki N. (ed): Immune disorders and opportunistic infection, 1989

    Google Scholar 

  39. Hoover RN: Lymphoma risks in populations with altered immunity--a search for mechanism. Cancer Res 52:5477s-5478s, 1992

    PubMed  CAS  Google Scholar 

  40. Penn I: Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:S328–S336 (suppl), 1993

    PubMed  CAS  Google Scholar 

  41. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al: Increased incidence of lymphoproliferative disorder after inununosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients [see comments]. N Engl J Med 323:1723–8, 1990

    Article  PubMed  CAS  Google Scholar 

  42. Zulman J, Jaffe R, Talal N: Evidence that the malignant lymphoma of Sjogren’s syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299:1215–20, 1978

    Article  PubMed  CAS  Google Scholar 

  43. Penn I: Tumors arising in organ transplant recipients. Adv Cancer Res 28:31–61, 1978

    Article  Google Scholar 

  44. Knowles DM: Etiology and pathogenesis of AIDS-related non--Hodgkin’s lymphoma. Hematol Oncol Clin North Am 10:1081–1109, 1996

    Article  PubMed  CAS  Google Scholar 

  45. Meeker TC, Shiramizu B, Kaplan L, et al: Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. Aids 5:669–74, 1991

    Article  PubMed  CAS  Google Scholar 

  46. Shiramizu B, Herndier B, Meeker T, et al: Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. J Clin Oncol 10:383–389, 1992

    PubMed  CAS  Google Scholar 

  47. Amadori A, Chieco-Bianchi L: B-cell activation and HIV-1 infection: deeds and misdeeds [see comments]. Immunol Today 11:374–9, 1990

    Article  PubMed  CAS  Google Scholar 

  48. Yarchoan R, Redfield RR, Broder S: Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest 78:439–47, 1986

    Article  PubMed  CAS  Google Scholar 

  49. Presant CA, Gala K, Wiseman C, et al: Human innunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer 60:1459–61, 1987

    Article  PubMed  CAS  Google Scholar 

  50. Ruff P, Bagg A, Papadopoulos K: Precursor T-cell lymphoma associated with human immunodeficiency virus type 1 (HIV-1) infection. First reported case. Cancer 64:39–42, 1989

    Article  PubMed  CAS  Google Scholar 

  51. Shibata D, Brynes RK, Rabinowitz A, et al: Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med 111:871–5, 1989

    PubMed  CAS  Google Scholar 

  52. Sternlieb J, Mintzer D, Kwa D, et al: Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome. Am J Med 85:445, 1988

    Article  PubMed  CAS  Google Scholar 

  53. Gonzalez-Clemente JM, Ribera JM, Campo E, et al: Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV- infected patient. Aids 5:751–5, 1991

    Article  PubMed  CAS  Google Scholar 

  54. Ciobanu N, Andreeff M, Safai B, et al: Lymphoblastic neoplasia in a homosexual patient with Kaposi’s sarcoma. Ann Intern Med 98:151–5, 1983

    PubMed  CAS  Google Scholar 

  55. Harper ME, Kaplan MH, Marselle LM, et al: Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. N Engl J Med 315:1073–8, 1986

    Article  PubMed  CAS  Google Scholar 

  56. Gold JE, Ghali V, Gold S, et al: Angiocentric immunoproliferative Iesionl T-cell non-Hodgkin’s lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature. Cancer 66:2407–13, 1990

    Article  PubMed  CAS  Google Scholar 

  57. Thomas JA, Cotter F, Hanby AM, et al: Epstein-Barr virus-related oral T-cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood 81:3350–6, 1993

    PubMed  CAS  Google Scholar 

  58. Chirmule N, Kalyanaraman VS, Saxinger C, et al: Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41. AIDS Res Hum Retroviruses 6:299–305, 1990

    Article  PubMed  CAS  Google Scholar 

  59. Lane HC, Masur H, Edgar LC, et al: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453–8, 1983

    Article  PubMed  CAS  Google Scholar 

  60. Rieckmann P, Poli G, Fox CH, et al: Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 147:2922–7, 1991

    PubMed  CAS  Google Scholar 

  61. Crapper RM, Deam DR, Mackay IR: Paraproteinemias in homosexual men with HIV infection. Lack of association with abnormal clinical or immunologic findings. Am J Clin Pathol 88:348–51, 1987

    PubMed  CAS  Google Scholar 

  62. Heriot K, Hallquist AE, Tomar RH: Paraproteinemia in patients with acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem 31:1224–6, 1985

    PubMed  CAS  Google Scholar 

  63. Vandermolen LA, Fehir KM, Rice L: Multiple myeloma in a homosexual man with chronic lymphadenopathy. Arch Intern Med 145:745–6, 1985

    Article  PubMed  CAS  Google Scholar 

  64. Konrad RJ, Kricka LJ, Goodman DB, et al: Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 328:1817–9, 1993

    Article  PubMed  CAS  Google Scholar 

  65. Przybylski GK, Goldman J, Ng VL, et al: Evidence for early B-cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 88:4620–9, 1996

    PubMed  CAS  Google Scholar 

  66. Bessudo A, Cherepakhin V, Johnson TA, et al: Favored use of immunoglobulin V(H)4 Genes in AIDS-associated B-cell lymphoma. Blood 88:252–60, 1996

    PubMed  CAS  Google Scholar 

  67. Liu M, Matinez-Maza O, Johnson M, et al: IL-6 induces target cell resistance to HIV-specific cytotoxic lysis. J Acquir Immune Defic Syndr Hum Retrovirol 9:321–331, 1995

    Article  PubMed  Google Scholar 

  68. Moses AV, Williams SE, Strussenberg JG, et al: HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nat Med 3:1242–9, 1997

    Article  PubMed  CAS  Google Scholar 

  69. Rabkin CS, Yang Q, Goedert JJ, et al: Chemokine and chemokine receptor gene variants and risk of non- Hodgkin’s lymphoma in human immunodeficiency virus-1-infected individuals. Blood 93:1838–42, 1999

    PubMed  CAS  Google Scholar 

  70. Connors M, Kovacs JA, Krevat S, et al: HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [see comments]. Nat Med 3:533–40, 1997

    Article  PubMed  CAS  Google Scholar 

  71. Hamilton-Dutoit SJ, Pallesen G, Karkov J, et al: Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation [letter]. Lancet 1:554–2, 1989

    Article  PubMed  CAS  Google Scholar 

  72. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al: AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149–63, 1991

    Google Scholar 

  73. Levine A, Shibata D, Weiss L: Molecular characteristics of intermediate/high (I/H) grade lymphomas (NHL) arising in HIV-positive vs. HIV-negative PTS: preliminary data from a population (POP) based study in the county of Los Angeles. Blood 80:1028, 1992

    Google Scholar 

  74. Cinque P, Brytting M, Vago L, et al: Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS- related primary lymphoma of the central nervous system. Lancet 342:398–401, 1993

    Article  PubMed  CAS  Google Scholar 

  75. Calzolari A, Papucci A, Baroni G, et al: Epstein-Barr virus infection and p53 expression in HIV-related oral large B-cell lymphoma. Head Neck 21:454–460, 1999

    Article  PubMed  CAS  Google Scholar 

  76. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al: Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413–20, 1997

    PubMed  CAS  Google Scholar 

  77. Young L, Alfieri C, Hennessy K, et al: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080–5, 1989

    Article  PubMed  CAS  Google Scholar 

  78. Kieff E, Liebowitz D: Epstein-Barr virus and its replication, in Fields B, Knipe D (eds): Virology, 1990, pp 1889

    Google Scholar 

  79. Sample J, Brooks L, Sample C, et al: Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A 88:6343–7, 1991

    Article  PubMed  CAS  Google Scholar 

  80. Rowe M, Rowe DT, Gregory CD, et al: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. Embo J 6:2743–51, 1987

    PubMed  CAS  Google Scholar 

  81. Shibata D, Weiss LM, Hernandez AM, et al: Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus [see comments] Blood 81:2102–9, 1993

    PubMed  CAS  Google Scholar 

  82. Murray RJ, Kurilla MG, Brooks JM, et al: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176:157–68, 1992

    Article  PubMed  CAS  Google Scholar 

  83. Levitskaya J, Comm M, Levitsky V, et al.Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685–8, 1995

    Article  PubMed  CAS  Google Scholar 

  84. Levitskaya J, Sharipo A, Leonchiks A, et al: Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 94:12616–21, 1997

    Article  PubMed  CAS  Google Scholar 

  85. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831–40, 1985

    Article  PubMed  CAS  Google Scholar 

  86. Mosialos G, Birkenbach M, Yalamanchilli R, et al: The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 80:389–399, 1995

    Article  PubMed  CAS  Google Scholar 

  87. Gregory CD, Dive C, Henderson S, et al: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612–4, 1991

    Article  PubMed  CAS  Google Scholar 

  88. Klein G: Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58:5–8, 1989

    Article  PubMed  CAS  Google Scholar 

  89. Burkhardt AL, Bolen JB, Kieff E, et al: An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 66:5161–7, 1992

    PubMed  CAS  Google Scholar 

  90. Knecht H, Raphael M, McQuain C, et al: Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876–81, 1996

    PubMed  CAS  Google Scholar 

  91. Kieff E: Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Nall Cancer Inst Monogr 23:7–14, 1998

    Article  CAS  Google Scholar 

  92. Huen DS, Henderson SA, Croom-Carter D, et al: The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549–60, 1995

    PubMed  CAS  Google Scholar 

  93. Sandvej K, Gratama JW, Munch M, et al: Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90:323–30, 1997

    PubMed  CAS  Google Scholar 

  94. Dolcetti R, Zancai P, De Re V, et al: Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin’s disease. Blood 89:1723–31, 1997

    PubMed  CAS  Google Scholar 

  95. Ometto L, Menin C, Masiero S, et al: Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood 90:313–22, 1997

    PubMed  CAS  Google Scholar 

  96. Moore KW, Vieira P, Fiorentino DF, et al: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein- Barr virus gene BCRFI [published erratum appears in Science 1990 Oct 26;250(4980):494]. Science 248:1230–4, 1990

    Article  PubMed  CAS  Google Scholar 

  97. Howard M, O’Garra A: Biological properties of interleukin 10. Immunol Today 13:198–200, 1992

    Article  PubMed  CAS  Google Scholar 

  98. Moore KW, O’Garra A, de Waal Malefyt R, et al: Interleukin-10. Arum Rev Immunol 11:165–90, 1993

    Article  CAS  Google Scholar 

  99. Hsu DH, de Waal Malefyt R, Fiorentino DF, et al: Expression of interleukin10 activity by Epstein-Barr virus protein BCRF1. Science 250:830–2, 1990

    Article  PubMed  CAS  Google Scholar 

  100. Masood R, Zhang Y, Bond MW, et al: Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma [see comments]. Blood 85:3423–30, 1995

    PubMed  CAS  Google Scholar 

  101. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt’s lymphoma constitutively secrete large quantities of interleukin-10 [see comments]. Blood 80:1289–98, 1992

    PubMed  CAS  Google Scholar 

  102. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma [see comments] Science 266:1865–9, 1994

    Article  PubMed  CAS  Google Scholar 

  103. Oksenhendler E, Duarte M, Soulier J, et al: Multicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients, Aids 10:61–7, 1996

    Article  PubMed  CAS  Google Scholar 

  104. Cesarman E KD: Kaposi’s sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Semin Diagn Pathol 14:54–66, 1997

    PubMed  CAS  Google Scholar 

  105. Rettig MB, Ma HJ, Vescio RA, et al: Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science 276:1851–4, 1997

    Article  PubMed  CAS  Google Scholar 

  106. Cesarman E, Chang Y, Moore PS, et al: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas [see comments]. N Engl J Med 332:1186–91, 1995

    Article  PubMed  CAS  Google Scholar 

  107. Karcher DS, Alkan S’ Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol 28:801–8, 1997

    Article  PubMed  CAS  Google Scholar 

  108. Katano H, Suda T, Morishita Y, et al: Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol 13:77–85, 2000

    Article  PubMed  CAS  Google Scholar 

  109. Mesri EA, Cesannan E, Arvanitakis L, et al: Human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183:2385–90, 1996

    Article  PubMed  CAS  Google Scholar 

  110. Lee H, Veazey R, Williams K, et al: Deregulation of cell growth by the K1 gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 4:435–40, 1998

    Article  PubMed  CAS  Google Scholar 

  111. Bais C, Santomasso B, Coso O, et al: G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [see comments] [published erratum appears in Nature 1998 Mar 12;392(6672):210]. Nature 391:86–9, 1998

    Article  PubMed  CAS  Google Scholar 

  112. Li M, Lee H, Guo J, et al: Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72:5433–40, 1998

    PubMed  CAS  Google Scholar 

  113. Zimring JC, Goodbourn S, Offermann MK: Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homologue that represses IRF-1-mediated transcription. J Virol 72:701–7, 1998

    PubMed  CAS  Google Scholar 

  114. Gao SJ, Boshoff C, Jayachandra S, et al: KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signalling pathway. Oncogene 15:1979–85, 1997

    Article  PubMed  CAS  Google Scholar 

  115. Muralidhar S, Pumfery AM, Hassani M, et al: Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) transforming gene [published erratum appears in J Virol 1999 Mar;73(3):2568]. J Virol 72:4980–8, 1998

    PubMed  CAS  Google Scholar 

  116. Cheng EH, Nicholas J, Bellows DS, et al: A Bc1–2 homologue encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Nall Acad Sci U S A 94:690–4, 1997

    Article  CAS  Google Scholar 

  117. Sand R, Sato T, Bohenzky RA, et al: Kaposi’s sarcoma-associated herpesvirus encodes a functional bd-2 homologue. Nat Med 3:293–8, 1997

    Article  Google Scholar 

  118. Djerbi M, Screpanti V, Catrina AI, et al: The inhibitor of death receptor signalling, FLICE-inhibitory protein defines a new class of tumor progression factors [In Process Citation]. J Exp Med 190:1025–32, 1999

    Article  PubMed  CAS  Google Scholar 

  119. Dairaghi DJ, Fan RA, McMaster BE, et al: HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 274:21569–74, 1999

    Article  PubMed  CAS  Google Scholar 

  120. Endres MJ, Garlisi CG, Xiao H, et al: The Kaposi’s sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP- I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med 189:1993–8, 1999

    Article  PubMed  CAS  Google Scholar 

  121. Kledal TN, Rosenkilde MM, Coulin F, et al: A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 277:1656–9, 1997

    Article  PubMed  CAS  Google Scholar 

  122. Boshoff C, Endo Y, Collins PD, et al: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [see comments]. Science 278:290–4, 1997

    Article  PubMed  CAS  Google Scholar 

  123. Arvanitakis L, Geras-Raaka E, Varma A, et al: Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [see comments]. Nature 385:347–50, 1997

    Article  PubMed  CAS  Google Scholar 

  124. Ganem D: KSHV and Kaposi’s sarcoma: the end of the beginning? Cell 91:157–60, 1997

    Article  PubMed  CAS  Google Scholar 

  125. Neipel F, Albrecht JC, Ensser A, et al: Human herpesvirus 8 encodes a homologue of interleukin-6. J Virol 71:839–42, 1997

    PubMed  CAS  Google Scholar 

  126. Knowles DM: Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Semin Diagn Pathol 14:67–82, 1997

    PubMed  CAS  Google Scholar 

  127. Nakamura H, Said JW, Miller CW, et al: Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 82:920–6, 1993

    PubMed  CAS  Google Scholar 

  128. Pelicci PG, Knowles DMd, Arlin ZA, et al: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 164:2049–60, 1986

    Article  PubMed  CAS  Google Scholar 

  129. Ballerini P, Gaidano G, Gong JZ, et al: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood 81:166–76, 1993

    PubMed  CAS  Google Scholar 

  130. Chaganti RS, Jhanwar SC, Koziner B, et al: Specific translocations characterize Burkitt’s-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood 61:1265–8, 1983

    PubMed  CAS  Google Scholar 

  131. Petersen JM, Tubbs RR, Savage RA, et al: Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome. Am J Med 78:141–8, 1985

    Article  PubMed  CAS  Google Scholar 

  132. Haluska FG, Russo G, Kant J, et al: Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis. Proc Natl Acad Sci U S A 86:8907–11, 1989

    Article  PubMed  CAS  Google Scholar 

  133. Neri A, Barriga F, Knowles DM, et al: Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A 85:2748–52, 1988

    Article  PubMed  CAS  Google Scholar 

  134. Gaidano G, Lo Coco F, Ye BH, et al: Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphoma: association with diffuse large-cell subtype. Blood 84:397–402, 1994

    PubMed  CAS  Google Scholar 

  135. Katler SP, Riggs SA, Cabanillas F: Aggressive non-Hodgkin’s lymphoma in immunocompromised homosexual males. Blood 66, 1985

    Google Scholar 

  136. Lowenthal DA, Straus DJ, Campbell SW, et al: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61:2325–37, 1988

    Article  PubMed  CAS  Google Scholar 

  137. Levine AM, Wernz JC, Kaplan L: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 266:84–88, 1991

    Article  PubMed  CAS  Google Scholar 

  138. Gill PS, Levine AM, Meyer PR, et al: Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med 78:742–8, 1985

    Article  PubMed  CAS  Google Scholar 

  139. Gill PS, Levine AM, Krailo M: AIDS-related malignant lymphoma: Results of prospective treatment trials. J Clin Oncol 5:1322–1328, 1987

    PubMed  CAS  Google Scholar 

  140. Knowles DM, Chamulak GA, Subar M: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients. Ann Intern Med 108:744–753, 1988

    PubMed  CAS  Google Scholar 

  141. Bermudez MA, Grant KM, Rodvien R, et al: Non-Hodgkin’s lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 86:71–6, 1989

    Article  PubMed  CAS  Google Scholar 

  142. Kaplan LD, Abrams DI, Feigal E: AIDS-associated non-Hodgkin’s lymphoma in San Francisco. JAMA 261:719–724, 1989

    Article  PubMed  CAS  Google Scholar 

  143. Kaplan MH, Susin M, Pahwa SG, et al: Neoplastic complications of HTLVIII infection. Lymphomas and solid tumors. Am J Med 82:389–96, 1987

    Article  PubMed  CAS  Google Scholar 

  144. Kaplan LD, Kahn JO, Crowe S, et al: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol 9:929–40, 1991

    PubMed  CAS  Google Scholar 

  145. Remick SC, McSharry JJ, Wolf BC: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin’s lymphoma. J Clin Oncol 11:1691–1702, 1993

    PubMed  CAS  Google Scholar 

  146. Freter CE: Acquired immunodeficiency syndrome-associated lymphomas. J Natl Cancer Inst Monogr 10:45–54, 1990

    PubMed  Google Scholar 

  147. von Gunten CF, Von Roenn JH: Clinical aspects of human immunodeficiency virus-related lymphoma. Curr Opin Oncol 4:894–9, 1992

    Article  Google Scholar 

  148. Raphael M, Gentilhomme O, Tulliez M, et al: Histopathologic features of high-grade non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med 115:15–20, 1991

    PubMed  CAS  Google Scholar 

  149. Straus DJ, Huang J, Testa MA, et al: Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin’s lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose mBACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol 16:3601–6, 1998

    PubMed  CAS  Google Scholar 

  150. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project [see comments]. N Engl J Med 329:987–94, 1993

    Article  Google Scholar 

  151. Navarro JT, Ribera JM, Oriol A, et al: International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin’s lymphoma treated with CHOP. A multivariate study of 46 patients. Haematologica 83:508–13, 1998

    PubMed  CAS  Google Scholar 

  152. Rossi G, Donisi A, Casari S, et al: The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin’s lymphoma. Cancer 86:2391–2397, 1999

    Article  PubMed  CAS  Google Scholar 

  153. Kaplan LD, Shiramizu B, Herndier B, et al: Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin’s lymphoma: identification of a subgroup with favorable clinical outcome. Blood 85:1727–35, 1995

    PubMed  CAS  Google Scholar 

  154. Kaplan LD, Straus DJ, Testa MA, et al: Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection. N Eng J Med 336:1641–1648, 1997

    Article  CAS  Google Scholar 

  155. Vaccher E, Tirelli U, Spina M, et al: Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin’s lymphomas: a single-institute study of 96 patients. J Clin Oncol 14:2217–23, 1996

    PubMed  CAS  Google Scholar 

  156. Evison J, Jost J, Lederberger B, et al: HIV-associated non-Hodgkin’s lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy (letter). AIDS 13:723–734, 1999

    Article  Google Scholar 

  157. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma [see comments]. N Engl J Med 328:1002–6, 1993

    Article  PubMed  CAS  Google Scholar 

  158. Gisselbrecht C, Oksenhendler E, Tirelli U: Human immunodeficiency virus-related lymphoma: Treatment with intensive combination chemotherapy. Am J Med 95:188–196, 1993

    Article  PubMed  CAS  Google Scholar 

  159. Tirelli U, Spina M, Gabarre J, et al. Treatment of HIV-related non-Hodgkin’s lymphoma adapted to prognostic factors. J AIDS 21; A32, 1999 (abstr 91).

    Google Scholar 

  160. Sparano JA, Wiernik PH, Hu X, et al: Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin’s lymphoma. J Clin Onc 14:3026–3035, 1996

    CAS  Google Scholar 

  161. Little R, al e: Dose-adjusted EPOCH chemotherapy (CT) in previously untreated HIV-associated non-hodgkin’s lymphoma (HIV-NHL). Proceedings of ASCO 18:10a, 1999

    Google Scholar 

  162. Straus D, Redden D, Hamzeh F, et al: Excessive Toxicity is not seen wit low-dose chemotherapy for HIV-associated non-Hodgkin lymphoma (HIV-NHL) in combination with highly active antiretroviral therapy (HAART). Blood 92:624a, 1998

    Google Scholar 

  163. Scadden DT, Schenkein DP, Bernstein Z, et al: Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin’s lymphoma. Cancer 83:2580–7, 1998

    Article  PubMed  CAS  Google Scholar 

  164. Holland HK, Saral R, Rossi JJ, et al: Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 111:973–81, 1989

    PubMed  CAS  Google Scholar 

  165. Vilmer E, Rhodes-Feuillette A, Rabian C, et al: Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 44:25–9, 1987

    Article  PubMed  CAS  Google Scholar 

  166. Hassett JM, Zaroulis CG, Greenberg ML, et al: Bone marrow transplantation in AIDS (letter). N Engl J Med 309:665, 1983

    PubMed  CAS  Google Scholar 

  167. Bowden RA, Coombs RW, Nikora BH, et al: Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. Am J Med 88:49N–52N, 1990

    Article  PubMed  CAS  Google Scholar 

  168. Bardini G, Re MC, Rosti G, et al: HIV infection and bone-marrow transplantation (letter;comment). Lancet 337:1163–1164, 1991

    Article  PubMed  CAS  Google Scholar 

  169. Giri N, Vowels MR, Ziegler JB: Failure of allogeneic bone marrow transplantation to benefit HIV infection. J Paediatr Child Health 28:331–3, 1992

    Article  PubMed  CAS  Google Scholar 

  170. Torlontano G, DiBartolomeo P, DiGirolamo G, et al: AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin. Haematologica 77:287–290, 1992

    PubMed  CAS  Google Scholar 

  171. Contu L, LaNasa G, Arras M, et al: Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant 12:669–671, 1993

    PubMed  CAS  Google Scholar 

  172. Campbell P, Iland H, Gibson J, et al: Syngeneic stem cell transplantation for HIV-related lymphoma. Br J Haematol 105:795–798, 1999

    Article  PubMed  CAS  Google Scholar 

  173. Gabarre J, Leblond V, Sutton L, et al: Autologous bone marrow transplantation in relapsed HIV-related non- Hodgkin’s lymphoma. Bone Marrow Transplant 18:1195–7, 1996

    PubMed  CAS  Google Scholar 

  174. Zaia J, al e: One year results after autologous stem cell transplantation using retrovirus-transduced peripheral blood progenitor cells in HIV-infected subjects. Blood 92:665a, 1998

    Google Scholar 

  175. Desai J, Mitnick R, Henry D, et al: Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin’s lymphoma. Cancer 86:1840–1847, 1999

    Article  PubMed  CAS  Google Scholar 

  176. Koyanagi Y, O’Brien WA, Zhao JQ, et al: Cytokines alter production of HIV1 from primary mononuclear phagocytes. Science 241:1673–5, 1988

    Article  PubMed  CAS  Google Scholar 

  177. Wang J, Roderiquez G, Oravecz T, et al: Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 72:7642–7, 1998

    PubMed  CAS  Google Scholar 

  178. Pluda JM, Yarchoan R, Smith PD, et al: Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection [see comments]. Blood 76:463–72, 1990

    PubMed  CAS  Google Scholar 

  179. Scadden DT, Bering HA, Levine JD, et al: Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi’s sarcoma [published erratum appears in J Clin Oncol 1992 Feb;10(2):346] [see comments]. J Clin Oncol 9:802–8, 1991

    PubMed  CAS  Google Scholar 

  180. Davey RT, Jr., Davey VJ, Metcalf JA, et al: A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection. J Infect Dis 164:43–52, 1991

    Article  Google Scholar 

  181. Scadden DT, Pickus O, Hammer SM, et al: Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on human immunodeficiency virus-type 1 (HIV-1). AIDS Res and Human Retroviruses 12:1151–1159, 1996

    Article  CAS  Google Scholar 

  182. Mladenovic J, Sevin A, Chiu S, et al: Decreased mobilization of CD34+ cells in advanced hIV-1 disease: Results of a multicenter prospective study. Blood 92:2808, 1998

    Google Scholar 

  183. Ozer H: American Society of Clinical Oncology guidelines for the use of hematopoietic colony-stimulating factors. Curr Opin Hematol 3:3–10, 1996

    Article  PubMed  CAS  Google Scholar 

  184. Nador RG, Cesarman E, Chadburn A, et al: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88:645–56, 1996

    PubMed  CAS  Google Scholar 

  185. Ely S, Powers J, Lewis D, et al: Kaposi’s sarcoma-associated herpesviruspositive primary effusion lymphoma arising in the subarachnoid space. Hum Pathol 30:981–984, 1999

    Article  PubMed  CAS  Google Scholar 

  186. DePond W, Said J, Tasaka T, et al: Kaposi’s sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Am J Surg Pathol 21:719–724, 1997

    Article  PubMed  CAS  Google Scholar 

  187. Carbone A, Gaidano G, Gloghini A, et al: AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 108:95–99, 1999

    PubMed  CAS  Google Scholar 

  188. Brown R, Campbell C, Lishman S, et al: Plasmablastic lymphoma: a new category of human immunodeficiency virus-related non-Hodgkin’s lymphoma. Clin Oncol 10:327–329, 1998

    Article  CAS  Google Scholar 

  189. Porter S, Diz Dios P, Kumar N, et al: Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:730–734, 1999

    Article  PubMed  CAS  Google Scholar 

  190. Harbinger U, Schabet M, Bitzer M, et al: Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neuro-oncol 43:219–226, 1999

    Article  Google Scholar 

  191. Bishburg E, Eng RH, Slim J, et al: Brain lesions in patients with acquired immunodeficiency syndrome. Arch Intern Med 149:941–3, 1989

    Article  PubMed  CAS  Google Scholar 

  192. Ciricillo SF, Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients [see comments]. J Neurosurg 73:720–4, 1990

    Article  PubMed  CAS  Google Scholar 

  193. Goldstein JD, Dickson DW, Moser FG, et al: Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation. Cancer 67:2756–65, 1991

    Article  PubMed  CAS  Google Scholar 

  194. Epstein L, DiCarlo F, Joshi V, et al: Primary Lymphoma of the CNS in children with AIDS. Pediatrics 82:355, 1988

    Google Scholar 

  195. Baumgartner JE, Rachlin JR, Beckstead JH, et al: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73:206–11, 1990

    Article  PubMed  CAS  Google Scholar 

  196. Antinori A, Ammassari A, De Luca A, et al: Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48:687–94, 1997

    Article  PubMed  CAS  Google Scholar 

  197. Cingolani A, De Luca A, Larocca LM, et al: Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma [see comments]. J Natl Cancer Inst 90:364–9, 1998

    Article  PubMed  CAS  Google Scholar 

  198. Gill PS, Graham RA, Boswell W, et al: A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging 1.134–41, 1986

    PubMed  CAS  Google Scholar 

  199. O’Malley J, Ziessman H, Kumar P, et al: Diagnosis of intracranial lymphoma in patients with AIDS: value of 201-TI single-photon emission computed tomography. AJR 163:417–421, 1994

    PubMed  Google Scholar 

  200. Ruiz A, Ganz W, Donovan J, et al: Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from Toxplasma encephalitis in AIDS patients. Am J Neuroradiol 15:1885–1894, 1994

    PubMed  CAS  Google Scholar 

  201. Hoffman J, Waskin H, Schifter t, et al: FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34, 1993

    Google Scholar 

  202. Pierce M, Johnson M, Maciunas R, et al: Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 123:594–598, 1995

    PubMed  CAS  Google Scholar 

  203. Heald A, Hoffman J, Bartlett J, et al: Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 7:337–346, 1996

    Article  PubMed  CAS  Google Scholar 

  204. Roelcke U, Leenders K: Positron emission tomography in patients with primary CNS lymphomas. J Neuro-oncol 43:231–236, 1999

    Article  CAS  Google Scholar 

  205. Luft BJ, Hafner R, Korzun AH, et al: Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med 329:995–1000, 1993

    Article  PubMed  CAS  Google Scholar 

  206. Formenti SC, Gill PS, Lean E, et al: Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer 63:1101–7, 1989

    Article  PubMed  CAS  Google Scholar 

  207. Bower M, Fife K, Sullivan A, et al: Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 35:601–604, 1999

    Article  PubMed  CAS  Google Scholar 

  208. Jacomet C, Girard PM, Lebrette MG, et al: Intravenous methotrexate for primary central nervous system non- Hodgkin’s lymphoma in AIDS [see comments]. Aids 11:1725–30, 1997

    Article  PubMed  CAS  Google Scholar 

  209. Chamberlain M, Kormanik P: AIDS-related central nervous system lymphomas. J Neuro-oncol 43:269–276, 1999

    Article  CAS  Google Scholar 

  210. Raez L, Cabral L, Cai JP, et al: Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2 AIDS Res Hum Retroviruses 15:713–9, 1999

    Article  CAS  Google Scholar 

  211. Franken M, Estabrooks A, Cavacini L, et al: Epstein-Barr virus-driven gene therapy for EBV-related lymphomas. Nat Med 2:1379–82, 1996

    Article  PubMed  CAS  Google Scholar 

  212. Robertson KD, Hayward SD, Ling PD, et al: Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15:6150–6159, 1995

    PubMed  CAS  Google Scholar 

  213. McGowan JP, Shah S: Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy [letter]. Aids 12:952–4, 1998

    PubMed  CAS  Google Scholar 

  214. Weller M: Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 43:237–239, 1999

    Article  PubMed  CAS  Google Scholar 

  215. Sparano JA, Lee S, Chen M, Hamilton S, Einzig AI, Ambinder RF, Henry DH, VonRoenn JH. Phase H trial of infusional cyclophosphamide, doxorubicin, and etoposide (CDE) in HIV-associated non-Hodgkin’s lymphoma: an Eastern Cooperative Oncology Group Trial. Proc Am Soc Clin Oncol 1999; 18; 12a (abstr 41).

    Google Scholar 

  216. Sparano JA, Tirelli U, Infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin’s lymphoma: a review of the Einstein, Aviano, and ECOG experience in 182 patients. J AIDS 23: Al2, 2000 (abstr S15).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Partners AIDS Research Center, Harvard Medical School, USA

    Kenneth Cohen & David T. Scadden

Authors
  1. Kenneth Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David T. Scadden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Albert Einstein College of Medicine, Montefiore Medical Center, New York, USA

    Joseph A. Sparano MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cohen, K., Scadden, D.T. (2001). Non-Hodgkin’s Lymphoma: Pathogenesis, Clinical Presentation, and Treatment. In: Sparano, J.A. (eds) HIV & HTLV-I Associated Malignancies. Cancer Treatment and Research, vol 104. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1601-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1601-9_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5635-6

  • Online ISBN: 978-1-4615-1601-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation